e-learning
resources
Virtual 2020
Pre-Congress Content
Inhaler devices in COPD: technical advances, adherence studies and more
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.
I. Markou (Pikermi, Greece), S. Tryfon (Thessaloniki, Greece), E. Tsikrika (Veroia, Greece), G. Krommidas (Athens, Greece), D. Lekkos (Ioannina, Greece), A. Athanassiou (Pikermi, Greece)
Source:
Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Session:
Inhaler devices in COPD: technical advances, adherence studies and more
Session type:
E-poster session
Number:
639
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Markou (Pikermi, Greece), S. Tryfon (Thessaloniki, Greece), E. Tsikrika (Veroia, Greece), G. Krommidas (Athens, Greece), D. Lekkos (Ioannina, Greece), A. Athanassiou (Pikermi, Greece). Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.. 639
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Lung function and reported dyspnea in Greek COPD patients under treatment with fluticasone/salmeterol FDC via Elpenhaler device with or without cardiovascular comorbidity - AEOLOS study.
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
COPD severity score and physical activity in Spanish primary care patients: the NEREA study
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Real-life COPD patients compared to large trial populations: An UNLOCK external validity study
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
The relationship between dyspnea and detection of depression in COPD patients (pts)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Depressive symptoms among patients with COPD according to smoking status: a Danish nationwide case–control study of 21?184 patients
Source: ERJ Open Res, 6 (4) 00036-2020; 10.1183/23120541.00036-2020
Year: 2020
Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Impact of age in the clinical expression of COPD in Greek patients
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1)
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
Source: International Congress 2018 – COPD management
Year: 2018
The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Determination of the optimal questionnaire to identify mental disorders COPD in patients (pts)
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Predictors of lung function decline: a retrospective study in COPD patients
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Prevalence of co-morbidities in Greek COPD patients in relation to the stage of the disease (COMPACT study)
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Determinants of dyspnea in COPD patients: the French PALOMB cohort
Source: International Congress 2018 – COPD around the world
Year: 2018
Frequency and impact of bronchiectasis in a cohort of patients in a COPD clinic
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept